HPV-FASTER: broadening the scope for prevention of HPV-related cancer

Nature Reviews. Clinical Oncology
F Xavier BoschJack Cuzick

Abstract

Human papillomavirus (HPV)-related screening technologies and HPV vaccination offer enormous potential for cancer prevention, notably prevention of cervical cancer. The effectiveness of these approaches is, however, suboptimal owing to limited implementation of screening programmes and restricted indications for HPV vaccination. Trials of HPV vaccination in women aged up to 55 years have shown almost 90% protection from cervical precancer caused by HPV16/18 among HPV16/18-DNA-negative women. We propose extending routine vaccination programmes to women of up to 30 years of age (and to the 45-50-year age groups in some settings), paired with at least one HPV-screening test at age 30 years or older. Expanding the indications for HPV vaccination and much greater use of HPV testing in screening programmes has the potential to accelerate the decline in cervical cancer incidence. Such a combined protocol would represent an attractive approach for many health-care systems, in particular, countries in Central and Eastern Europe, Latin America, Asia, and some more-developed parts of Africa. The role of vaccination in women aged >30 years and the optimal number of HPV-screening tests required in vaccinated women remain important research ...Continue Reading

References

Jul 1, 1988·Gynecologic Oncology·Y van der GraafG A Zielhuis
Jun 17, 1995·Lancet·J CuzickJ Guillebaud
Apr 12, 2001·The New England Journal of Medicine·J MorkJ Dillner
Jan 30, 2004·Salud pública de México·Eduardo Lazcano-PonceMauricio Hernández-Avila
Nov 3, 2005·JAMA : the Journal of the American Medical Association·Lynette DennyThomas C Wright
Apr 4, 2006·Sexually Transmitted Infections·K McCafferyJ Wardle
Jun 24, 2006·Nature Reviews. Cancer·Steven Gutman, Larry G Kessler
Sep 5, 2006·Vaccine·D Maxwell Parkin, Freddie Bray
Sep 5, 2006·Vaccine·Jack CuzickJane Wardle
Aug 8, 2007·Australian and New Zealand Journal of Public Health·Helen MarshallPeter Baghurst
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Allan HildesheimUNKNOWN Costa Rican HPV Vaccine Trial Group
Oct 6, 2007·Journal of Lower Genital Tract Disease·Neal M LonkyBradley J Monk
Oct 19, 2007·The New England Journal of Medicine·Pontus NauclerJoakim Dillner
Feb 2, 2008·International Journal of Cancer. Journal International Du Cancer·Jack CuzickWilliam P Soutter
May 28, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·E J DasbachE H Elbasha
Jul 22, 2008·BMJ : British Medical Journal·Mark JitW John Edmunds
Aug 22, 2008·The New England Journal of Medicine·Jane J Kim, Sue J Goldie
Sep 12, 2008·The Lancet Oncology·Francesca CarozziUNKNOWN New Technologies for Cervival Cancer Screening (NTCC) Working Group
Oct 14, 2008·Vaccine·Jane J KimSue J Goldie
Apr 3, 2009·The New England Journal of Medicine·Rengaswamy SankaranarayananKetayun A Dinshaw
Jun 6, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Elamin H ElbashaEliav Barr
Jun 16, 2009·Biologicals : Journal of the International Association of Biological Standardization· Who
Oct 27, 2009·Archives of Medical Research·Eduardo L FrancoFrançois Coutlée
Nov 12, 2009·Journal of the National Cancer Institute·Maarit LeinonenAhti Anttila
Jan 21, 2010·Journal of Medical Economics·Erik J DasbachElamin H Elbasha
Jan 22, 2010·The Lancet Oncology·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer screening (NTCC) Working Group
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Apr 16, 2010·International Journal of Technology Assessment in Health Care·Jens Olsen, Martin Rudbeck Jepsen
Oct 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Erik J DasbachElamin H Elbasha
Oct 15, 2010·Journal of the National Cancer Institute·Mahboobeh SafaeianUNKNOWN Costa Rican Vaccine Trial Group
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Nov 16, 2010·The Lancet Infectious Diseases·Nienke J VeldhuijzenJanneke Hhm van de Wijgert
Nov 19, 2010·American Journal of Preventive Medicine·Yan CuiJonathan E Fielding

❮ Previous
Next ❯

Citations

Mar 13, 2016·Seminars in Oncology·Malgorzata E WojtowiczAsad Umar
Jun 8, 2017·Diagnostic Cytopathology·Julieta E BarroetaCarolyn E Grotkowski
Apr 4, 2017·International Journal of Cancer. Journal International Du Cancer·Catherine de MartelSilvia Franceschi
Dec 3, 2016·Nature Reviews. Disease Primers·Mark SchiffmanSilvia Franceschi
Mar 11, 2017·Preventive Medicine·Mauricio Maza, Julia C Gage
Dec 9, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mario PoljakEda Vrtačnik Bokal
Jun 28, 2017·PLoS Medicine·Paul Bloem, Ikechukwu Ogbuanu
Sep 22, 2017·Viruses·Patti E Gravitt, Rachel L Winer
Oct 11, 2017·Viruses·Samuel AlizonIgnacio G Bravo
May 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emily A BurgerPhilip E Castle
Jan 10, 2018·Biotechnology Progress·Ana M AlmeidaÂngela Sousa
Feb 7, 2018·The Journal of Infectious Diseases·Kevin G J Pollock
May 2, 2018·Expert Review of Vaccines·Talía MalagónEduardo L Franco
Jan 18, 2018·International Journal of Cancer. Journal International Du Cancer·Kate CuschieriSilvia Franceschi
Jul 25, 2017·International Journal of Cancer. Journal International Du Cancer·S VaccarellaF Bray
Aug 26, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Austin M OberlinCarla J Chibwesha
Jul 1, 2017·F1000Research·Lai-Yang Lee, Suzanne M Garland
Jan 31, 2019·Salud pública de México·Claudia RoblesMaribel Almonte
Jun 12, 2019·Human Vaccines & Immunotherapeutics·L León-MaldonadoE Lazcano-Ponce
Aug 12, 2016·Infectious Agents and Cancer·Wafaa Mohamed HusseinMeriem Khyatti
Jan 29, 2020·PLoS Medicine·Karin Sundström, K Miriam Elfström
Dec 11, 2019·Journal of the National Cancer Institute·Emily A BurgerJane J Kim
Mar 24, 2020·Cancer Cytopathology·Jon Frias-GomezUNKNOWN Screenwide Team
Apr 24, 2020·Current Pharmaceutical Design·Saule BalmagambetovaElnara Ismagulova
Mar 10, 2017·Expert Review of Molecular Diagnostics·Ana Gradíssimo, Robert D Burk
Aug 6, 2020·Frontiers in Immunology·Xu ZhouYang Lin
Jul 12, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Gina OgilvieJose Jeronimo
Jun 15, 2019·International Journal of Cancer. Journal International Du Cancer·Laura CostasUNKNOWN Screenwide Team
Jun 26, 2020·Frontiers in Cellular and Infection Microbiology·María Guadalupe Flores-MiramontesAdriana Aguilar-Lemarroy
Mar 3, 2018·Nature Reviews. Cancer·Richard B S Roden, Peter L Stern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Kevin Ault, Keith Reisinger
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
Carlo La Vecchia, Stefania Boccia
© 2021 Meta ULC. All rights reserved